Strategic Moves to Accelerate Growth

109 Pages·2014·3.75 MB·English

PT Merck Tbk
Laporan Tahunan 2013 Annual Report
Strategic Moves
to Accelerate Growth
DAFTAR ISI | CONTENTS
Daftar Isi
Table of Contents
01 44-45
01 Mengenai Tema 44 Sumber Daya Manusia
About the Theme Human Resources

02–11 46–53
02 Ikhtisar Keuangan 46 Tata Kelola Perusahaan
Ikhtisar Kinerja Financial Highlights Tata Kelola Good Corporate Governance
2013 04 Ikhtisar Saham Perusahaan 46 Rapat Umum Pemegang Saham (RUPS)
Performance Share Highlights Good Corporate General Meeting of Shareholders (GMS)
Highlights 06 Peristiwa dan Pencapaian Penting 2013 Governance 47 Dewan Komisaris
in 2013 Major Events and Milestones in 2013 The Board of Commissioners
11 Penghargaan 2013 47 Direksi
Awards 2013 The Board of Directors
49 Komite Audit
The Audit Committee
12–17
12 Profil Perseroan 50 Pengendalian Internal
Sekilas Mengenai Profile of the Company Internal Control
Merck 13 Sejarah Singkat Perseroan 51 Sekretaris Perusahaan
Merck in Brief Brief History of the Company Corporate Secretary
14 Visi dan Misi Perseroan 53 Faktor Risiko
Corporate Vision and Mission Risk Factors
14 Filosofi Perseroan
Corporate Philosophy
15 Nilai-Nilai Perseroan
54-55
Corporate Values 54 Tanggung Jawab Sosial Perusahaan
16 Data Perseroan Corporate Social Responsibility
Corporate Data
16 Struktur Organisasi
56
Organization Structure 56 Lembaga & Profesi Penunjang
17 Kronologis Pencatatan Saham Perseroan Pasar Modal
Chronology of the Company’s Stock Listing Professional Parties

18–29 57–58
19 Sambutan Presiden Komisaris 57 Pernyataan Dewan Komisaris PT Merck Tbk
Laporan President Commissioner's Message Surat Pernyataan atas Laporan Tahunan 2013
Manajemen 21 Profil Dewan Komisaris Statement letter The Board of Commissioners’ Statement of
Management The Board of Commissioners' Profile PT Merck Tbk for Annual Report 2013
Report 22 Sambutan Presiden Direktur 58 Pernyataan Direksi PT Merck Tbk
President Director's'Message atas Laporan Tahunan 2013
27 Profil Direksi The Board of Directors’ Statement of
The Board of Directors' Profile PT Merck Tbk for Annual Report 2013

30–43 59
30 Tinjauan Bisnis 59 Laporan Keuangan 31 Desember 2013
Analisis dan Business Review Financial Statements 31 December 2013
Pembahasan 31 Tinjauan Operasional
Manajemen Operational Review
Management 40 Tinjauan Keuangan
Discussion and Financial Review
Analysis
PT Merck Tbk 2013 ANNUAL REPORT 01 MENGENAI TEMA
ABOUT THE THEME
Mengenai Tema
About the Theme
Tahun 2013 merupakan tahun yang penuh tantangan bagi industri farmasi dan bahan kimia, khususnya di Indonesia. Ditandai dengan
penurunan ekonomi di semester kedua, yang memicu fluktuasi nilai tukar Rupiah terhadap Dollar AS pada penutupan tahun, di angka
Rp12.189, selain itu juga adanya pengetatan peraturan terhadap lingkungan. Indikator makroekonomi lainnya juga melambat seperti
terlihat pada Produk Domestik Bruto (PDB) yang menurut Bank Indonesia berada di posisi 5,7%, sedikit lebih rendah dari tahun
sebelumnya yaitu sebesar 6,2%.
Sebagai pemain utama dalam industri farmasi dan bahan kimia, Perseroan berupaya untuk mengatasi tantangan-tantangan
tersebut dengan menerapkan strategi baru serta melanjutkan program "Fit for 2018”, melalui upaya-upaya yang signifikan untuk
merestrukturisasi dan membentuk bisnis dalam rangka meningkatkan daya saing jangka panjang.
Manajemen Perseroan telah berhasil mengatasi tekanan tersebut dan memenuhi kebutuhan pelanggan. Dengan demikian serangkaian
langkah strategis telah membantu Perseroan sepenuhnya dalam memanfaatkan perubahan yang terjadi dalam industri farmasi dan
bahan kimia sekaligus menyeimbangkan risiko untuk mempercepat pertumbuhan, sehingga menghasilkan kinerja yang kuat sesuai
dengan strategi dan target yang ditetapkan untuk tahun 2013.
2013 was a challenging year for the pharmaceutical and chemicals industry, particularly in Indonesia. Marked by an economic downturn
in the second half, which triggered foreign exchange fluctuation leading the Rupiah to close the year at Rp12,189 to the US dollar, it also
saw a tightening of the regulatory environment. Other macroeconomic indicators have been slowing down as indicated by the GDP
which stood at 5.7%, according to Bank Indonesia, just slightly lower than the previous year’s figure of 6.2%.
As a major operator in the pharmaceutical and chemical industries, the Company endeavored to overcome those challenges by applying
new strategies as well as continuing the implementation of the “Fit for 2018” Program, through which we are undertaking significant
efforts to restructure and reshape the business to improve long-term competitiveness.
The Company’s management has been successful in navigating such pressures and meeting evolving customer needs. Thus a series of
strategic moves have helped the Company fully leverage the changes in the pharma and chemical industry while balancing risk in order to
accelerate growth, enabling us to deliver a strong overall performance against the strategic initiatives and targets set for 2013.
IKHTISAR KINERJA 2013 02 LAPORAN TAHUNAN 2013 PT Merck Tbk
Ikhtisar Keuangan
Financial Highlights
LAPORAN POSISI KEUANGAN | STATEMENTS OF FINANCIAL POSITION
Tahun Fiskal Berakhir 31 Desember Fiscal Years Ended 31 December
(dalam jutaan Rupiah) 2013 2012 2011 (in million Rupiah)
Piutang 137,784 68,546 108,103 Receivables
Persediaan 249,319 237,577 123,559 Inventories
Aset Lancar Lainnya 201,135 157,760 260,064 Other Current Assets
Jumlah Aset Lancar 588,238 463,883 491,726 Total Current Assets
Aset Tetap 61,627 63,318 61,536 Fixed Assets
Aset Tidak Lancar Lainnya 47,081 42,230 31,127 Other Non-Current Assets
JUMLAH ASET 696,946 569,431 584,389 TOTAL ASSETS
Jumlah Liabilitas Jangka Pendek 147,818 119,828 65,431 Total Current Liabilities
Jumlah Liabilitas Jangka Panjang 36,909 32,861 24,776 Total Non-Current Liabilities
Hak Minoritas 0 0 0 Minority Interest
JUMLAH LIABILITAS 184,727 152,689 90,207 TOTAL LIABILITIES
Modal Saham 22,400 22,400 22,400 Share Capital
Tambahan Modal Disetor 17,562 17,562 17,562 Additional Paid-In Capital
Selisih Penilaian Kembali Aset Tetap 0 0 0 Revaluation of Fixed Assets
Saldo Laba 472,257 376,780 454,220 Retained Earnings
JUMLAH EKUITAS 512,219 416,742 494,182 TOTAL EQUITY
JUMLAH LIABILITAS DAN EKUITAS 696,946 569,431 584,389 TOTAL LIABILITIES AND EQUITY
Jumlah Modal Kerja 440,420 344,055 426,295 Total Working Capital
Jumlah Investasi 9,971 13,205 6,180 Total Investment
PENJUALAN PER SEKTOR BISNIS PENJUALAN PER SEKTOR BISNIS TAHUN 2013
SALES BY BUSINESS SECTOR SALES BY BUSINESS SECTOR IN 2013
(dalam jutaan Rupiah in million Rupiah) (dalam jutaan Rupiah in million Rupiah)
800,000
736,305
700,000 5 62%
0
3
600,000 36,
500,000 598,393 70,974 7 43587%,647
400,000 5 7
4
6
320000,,000000 20,139 358,903 457,
3
100,000
0
2011 2012 2013 Farmasi | Pharmaceuticals Bahan Kimia | Chemicals
PT Merck Tbk 2013 ANNUAL REPORT 03 PERFORMANCE HIGHLIGHTS IN 2013
LAPORAN LABA RUGI KOMPREHENSIF | STATEMENTS OF COMPREHENSIVE INCOME
(dalam jutaan Rupiah) 2013 2012 2011 (in million Rupiah)
Penjualan 1,193,952 929,877 918,532 Sales
Laba Bruto 545,480 424,442 482,138 Gross Profit
Laba Usaha 230,026 141,248 278,628 Results from Operating Activities
Jumlah Laba Komprehensif 175,445 107,808 231,159 Total Comprehensive Income
Rasio Lancar 3.98 3.87 7.52 Current Ratio
Rasio Cepat 2.29 1.89 5.63 Quick Ratio
Rasio Liabilitas terhadap Ekuitas 0.36 0.37 0.18 Leverage Ratio
Rasio Liabilitas terhadap Aset 0.27 0.27 0.15 Liabilities to Total Assets Ratio
Rasio Laba terhadap Jumlah Aset (%) 25.17 18.93 39.56 Return on Total Assets (%)
Rasio Pembayaran Dividen (%) 79.80* 74.18 80.14 Dividend Payout Ratio (%)
Laba per Saham (dalam Rupiah penuh) 7,832 4,813 10,320 Earnings per Share (in whole Rupiah)
Dividen per Saham (dalam Rupiah penuh) 6,250* 3,570 8,270 Dividend per Share (in whole Rupiah)
Nilai Buku per Saham (dalam Rupiah penuh) 22,867 18,605 22,062 Book Value per Share (in whole Rupiah)
Nominal per Saham (dalam Rupiah penuh) 1,000 1,000 1,000 Par Value per Share (in whole Rupiah)
Jumlah Saham yang Beredar (dalam ribuan unit) 22,400 22,400 22,400 Number of Shares (in thousand units)
* yang diajukan * proposed
Harga Saham Bursa Efek Indonesia Indonesia Stock Exchange Share Price
Tertinggi (dalam Rupiah penuh) 235,500 156,500 133,000 Highest (in whole Rupiah)
Terendah (dalam Rupiah penuh) 150,000 133,000 90,000 Lowest (in whole Rupiah)
KINERJA KEUANGAN FINANCIAL PERFORMANCE
Perubahan Penjualan (%) 28.40 1.24 15.44 Change in Sales (%)
Perubahan Laba Komprehensif (%) 62.74 (53.36) 94.59 Change in Comprehensive Income (%)
Rasio Laba terhadap Penjualan (%) 14.69 11.59 25.17 Return on Sales (%)
Rasio Laba terhadap Ekuitas (%) 34.25 25.87 46.78 Return on Equity (%)
PT MERCK Tbk’s KEY FIGURES FREE CASH FLOW
(dalam jutaan Rupiah in million Rupiah) (dalam jutaan Rupiah in million Rupiah)
250,000
2013 2012 Change 3
4
6
5,
200,000 24
Sales 1,193,952 929,877 264,075
150,000
Operating Result 230,026 141,248 88,778
1
Free Cash Flow 120,031 75,520 44,511 100,000 03
0,
2
1
ROS in % 19.3 15.3 0
50,000 2
5
5,
7
ROCE in % 41.9 58.1
0
2011 2012 2013
IKHTISAR KINERJA 2013 04 LAPORAN TAHUNAN 2013 PT Merck Tbk
Ikhtisar Saham
Share Highlights
INFORMASI HARGA SAHAM DUA TAHUN TERAKHIR
SHARE PRICE INFORMATION FOR THE LAST TWO YEARS
Tahun Transaksi per kuartal Tertinggi (Rp) Terendah (Rp) Penutupan (Rp) Jumlah Saham (Unit)
Year Transaction per quarterly Highest (Rp) Lowest (Rp) Closing (Rp) Volume (Unit)
Januari - Maret | January - March 152,000 150,000 152,000 4,000
April - Juni | April - June 235,500 210,000 210,000 75,000
2013
Juli - September | July - September 215,000 151,500 215,000 27,000
Oktober - Desember | October - December 189,000 170,000 189,000 59,000
Januari - Maret | January - March 147,000 133,000 147,000 61,500
April - Juni | April - June 150,000 145,000 145,000 48,000
2012
Juli - September | July - September 152,000 146,750 149,000 3,000
Oktober - Desember | October - December 156,500 139,000 152,000 29,000
Sumber: Bursa Efek Indonesia/ Source: Indonesia Stock Exchange
HARGA SAHAM MERCK BANDING INDEKS HARGA SAHAM GABUNGAN (IHSG)
MERCK’S SHARE PRICE COMPARED TO INDONESIA COMPOSITE INDEX
indeks (%) | index (%)
250
225
200
175
150
125
PT Merck Tbk
100 IHSG
75
50
25
0
1/1/13 1/2/13 1/3/13 1/4/13 1/5/13 1/6/13 1/7/13 1/8/13 1/9/13 1/10/13 1/11/13 1/12/13
PT Merck Tbk 2013 ANNUAL REPORT 05 PERFORMANCE HIGHLIGHTS IN 2013
STRUKTUR KEPEMILIKAN SAHAM
SHAREHOLDER STRUCTURE BY INVESTOR
1.0% 4.8%
Institusi Asing Lain/ Other Foreign Institutions
1.0% 19.3%
Institusi Asing/ Foreign Institution
Institusi Lokal/ Local Institution
Merck Holding GmbH
73.9% Perorangan Asing/ Foreign Individual
Perorangan Lokal/ Local Individual
PEMEGANG SAHAM DAN KEPEMILIKAN SAHAM
SHAREHOLDER AND SHAREHOLDINGS
Pemegang Saham Saham Ditempatkan dan Disetor Penuh Persentase Kepemilikan Saham
Shareholders The Number of Shares Issued and Fully Paid Percentage of Shares Ownership
Merck Holding GmbH 16,574,150 73.99%
Emedia Export Company mbH 2,835,596 12.66%
Citibank New York S/A Rainbow Fund, LP 837,200 3.74%
BP2S Singapore/Fully Taxable 271,500 1.21%
Robert Alexander Stone 216,000 0.96%
TH Setyowati Suroso 183,900 0.82%
BBH Boston S/A Aberdeen Indonesia Fund Inc 125,000 0.56%
Caceis Bank France Non-Treaty A/C 121,000 0.54%
Parulian Simanjuntak
250 0.00%
(Komisaris Independen/Independent Commissioner)
Masyarakat Lainnya/Other Publics 1,235,404 5.52%
TOTAL 22,400,000 100.00%
IKHTISAR KINERJA 2013 06 LAPORAN TAHUNAN 2013 PT Merck Tbk
Peristiwa dan Pencapaian Penting 2013
Major Events and Milestones in 2013
2-23/02/2013 20/03/2013 20-22/03/2013
2-23 Februari 2013 2-23 February 2013
Simposium Glucophage XR 750 mg di 5 Kota Besar Glucophage XR 750 mg Symposium in 5 Major Cities
Divisi Obat Resep Merck Serono sukses menggelar simposium The Prescription Division of Merck Serono successfully held the
peluncuran Glucophage XR 750 mg di 5 kota besar (Semarang, Glucophage XR 750 mg launch Symposium in 5 major cities (Semarang,
Jakarta, Medan, Bandung dan Surabaya), dihadiri oleh 2.500 dokter. Jakarta, Medan, Bandung and Surabaya), attended by a total of 2,500
Simposium bersama juga diadakan di Pekanbaru (100 dokter), doctors. Joint symposiums were also held in Pekanbaru (100 doctors),
Makassar (100 dokter), Batam (100 dokter) dan Solo (200 dokter). Makassar (100 doctors), Batam (100 doctors) and Solo (200 doctors).
22-24 Februari 2013 22-24 February 2013
Concor: The 5th Scientific Meeting on Hypertension (InaSH), Concor: The 5th Scientific Meeting on Hypertension (InaSH),
22-24 Februari 2013, Jakarta 22-24 February 2013, Jakarta
Acara ini dikenal luas sebagai InaSH, sebuah acara ilmiah terkemuka This event is widely known as InaSH, a reputable scientific event and
dan forum di mana para profesional di bidang kesehatan yang a forum where health care professionals related to hypertension
berhubungan dengan hipertensi (neurolog, kardiolog dan nephrolog) (neurologists, cardiologists and nephrologists) share recent advances
saling berbagi perkembangan terbaru seputar hipertensi. Simposium and developments on hypertension. This symposium was attended by
ini dihadiri oleh 400 dokter spesialis. 400 specialist doctors.
20 Maret 2013 20 March 2013
Rapat Umum Pemegang Saham Tahunan dan Public Expose Annual General Meeting of Shareholders and Public Expose
Perseroan mengadakan Rapat Umum Pemegang Saham Tahunan The Company held its Annual General Meeting of Shareholders to
untuk melaporkan kinerja tahun buku 2012 di kantor Merck di Pasar report its 2012 performance at Merck’s office in Pasar Rebo, East
Rebo, Jakarta Timur. Acara ini dilanjutkan dengan Public Expose yang Jakarta. This was followed by a Public Expose for journalists from
dihadiri oleh wartawan dari berbagai media. various media.
20-22 Maret 2013 20-22 March 2013
Merck Millipore pada Konvensi Farmasi Terbesar di ASEAN Merck Millipore at the Biggest ASEAN Pharmaceutical Convention
Merck Millipore berpartisipasi dalam pameran bahan farmasi Merck Milipore participated in the largest exhibition of
terbesar di regional: Konvensi Bahan Farmasi se-Asia Tenggara, pharmaceutical ingredients in the region: the Convention on
di Jakarta International Expo. Merck Millipore menghadirkan dua Pharmaceutical Ingredients Southeast Asia, at Jakarta International
pembicara dari Jerman, keduanya berbicara dalam seminar teknis Expo. Merck Millipore presented two speakers from Germany, both of
yang diadakan bagi para pengunjung pameran. whom conducted technical seminars for the exhibition visitors.
PT Merck Tbk 2013 ANNUAL REPORT 07 PERFORMANCE HIGHLIGHTS IN 2013
27/03/2013 30/03-19/05/2013 03/04/2013
25-26 Maret 2013 25-26 March 2013
Lokakarya di Perusahaan Masterbatch Workshop at Masterbatch Company
Dalam rangka membekali pelanggan dengan “know how” yang berkaitan In order to equip customers with knowhow related to our products,
dengan produk kami, Divisi Performance Materials mengadakan lokakarya Merck Performance Material division held a workshop at multinational
di perusahaan-perusahaan Masterbatch, yaitu perusahaan multinasional Masterbatch companies who produce plastic material for packaging,
yang memproduksi bahan plastik untuk kemasan, terutama untuk especially for cosmetic packaging. During the workshop we showed our
kemasan kosmetik. Selama lokakarya, pelanggan ditunjukkan bagaimana customers how to select attractive colors by using the “Effect Formulator”
memilih warna yang menarik dengan menggunakan “ Effect Formulator “ guidance in order match end user or brand owner demands.
sehingga dapat memenuhi kebutuhan setiap pemakai atau brand owner.
27 Maret 2013 27 March 2013
Edukasi Anemia dan Peluncuran Tanya Anemia Center Education of Anemia and launched Tanya Anemia Center
Divisi Kesehatan Konsumen meluncurkan Tanya Anemia Center dengan The Consumer Health Division launched Tanya Anemia Center to
tujuan untuk mengedukasi masyarakat mengenai gejala anemia dan educate public on anemia symptoms and to give early treatment
memberikan rekomendasi pencegahan dini. Berbagai layanan yang recommendations. The range of services provided at Tanya Anemia
diberikan di Tanya Anemia Center dapat diperoleh secara gratis oleh Center are accessible for free by anyone at any age and are
siapapun dari berbagai golongan usia dan tersedia di Jakarta, Bogor, available in Jakarta, Bogor, Depok, Tangerang, Bekasi, Bandung,
Depok, Tangerang, Bekasi, Bandung, Cirebon, Surabaya, Semarang, Cirebon, Surabaya, Semarang, Yogyakarta, Magelang, Solo, and
Yogyakarta, Magelang, Solo, dan Malang. Malang.
30 Maret-19 Mei 2013 30 March-19 May 2013
Dukungan lebih lanjut untuk Edukasi Bayi Tabung Further Support for In-Vitro Fertilization Education
Untuk mensosialisasikan program fertilisasi in-vitro (bayi tabung) To socialize the in-vitro fertilization program in Indonesia, the
di Indonesia, Divisi Obat Resep Merck Serono berkolaborasi dengan Prescription Division of Merck Serono collaborated with PERFITRI,
PERFITRI, Asosiasi Dokter Bayi Tabung Indonesia, dalam mengedukasi the Indonesian Association of In-Vitro Specialization Specialists, to
pasangan infertil mengenai teknologi bayi tabung. Bagian dari program educate infertile couples about In-Vitro Fertilization Technology. This
tersebut adalah konsultasi gratis di berbagai pusat perbelanjaan ternama program included free consultations at various prominent malls in
di Jakarta pada akhir pekan tanggal 30 Maret hingga 19 Mei 2013. Jakarta at weekends between March 30 and May 19, 2013.
3 April 2013 3 April 2013
Merck Bersama PERDOSSI Luncurkan Neuropathy Service Point Merck Joined PERDOSSI to Launch Neuropathy Service Point
Dalam rangka meningkatkan kesadaran dan pengetahuan tentang In order to boost awareness and knowledge about the early symptoms
gejala awal neuropati, PERDOSSI (Perhimpunan Dokter Spesialis Saraf of neuropathy, PERDOSSI (the Indonesian Association of Neurologists)
Indonesia) dan Divisi Kesehatan Konsumen, melalui Neurobion 5000, and Consumer Health Division, through Neurobion 5000, extended
memperluas aktivitas Neuropathy Service Point (NSP) dengan peluncuran their Neuropathy Service Point (NSP) activity with the re-launch of NSP,
kembali NSP yang tersedia di kota-kota besar seperti Jakarta, Surabaya, which are available in major cities including Jakarta, Surabaya, Bandung,
Bandung, Semarang, Medan, Padang, dan Pekanbaru. Semarang, Medan, Padang, and Pekanbaru.
IKHTISAR KINERJA 2013 08 LAPORAN TAHUNAN 2013 PT Merck Tbk
12/04/2013 14/04/2013 03/05/2013 06/05/2013
5-7 April 2013 5-7 April 2013
Concor: Pertemuan Ilmiah Tahunan ke-21 Asosiasi Jantung Concor: The 21st Annual Scientific Meeting of Indonesian Heart
Indonesia (ASMIHA), Jakarta Association (ASMIHA), Jakarta
ASMIHA adalah pertemuan tahunan terbesar dan bergengsi skala ASMIHA is the national’s largest and prestigious annual meeting for
nasional untuk ahli jantung, internis, neurolog, dokter dan ilmuwan yang cardiologists, internists, neurologists, GPs and scientists dedicated to
berdedikasi pada ilmu penyakit jantung dan gangguan yang berkaitan the science of cardiovascular diseases and associated disorders. The
dengan itu. Divisi Obat Resep Merck Serono berpartisipasi dalam Prescription Division of Merck Serono participated in this Symposium
simposium dan pameran yang dihadiri oleh 350 dokter spesialis ini. and Exhibition, which was attended by 350 specialist doctors.
12 April 2013 12 April 2013
Edukasi tentang Infertilitas dan Bayi Tabung Education on Infertility and In-Vitro Fertilization
Selain konsultasi gratis, Divisi Obat Resep Merck Serono dan PERFITRI Besides free consultations, the Prescription Division of Merck Serono and
juga mengadakan talkshow mengenai infertilitas dan bayi tabung pada PERFITRI also held a talkshow on infertility and In-Vitro Fertilization on
tanggal 12 April 2013 di Lobby Lounge Bimasena, Hotel Dharmawangsa, April 12, 2013 at the Bimasena Lobby Lounge, Hotel Dharmawangsa, in
bekerjasama dengan majalah Femina. Talkshow ini dihadiri oleh pembaca cooperation with Femina Magazine. The talkshow was attended by readers
Femina dan dokter anggota PERFITRI sebagai pembicara. of Femina Magazine and doctors of PERFITRI members as the speakers.
14 April 2013 14 April 2013
2013 Youth Take Action: “Dare to Change” 2013 Youth Take Action: “Dare to Change”
Untuk empat tahun berturut-turut, Perseroan mengadakan Youth Take For the fourth year in a row, the Company held Youth Take Action
Action (YTA), di mana 80 siswa SMP dan SMA yang tinggal di Kelurahan (YTA), in which 80 Junior High School and Senior High School students
Gedong mengasah bakat mereka di bidang fotografi, teater, tari, web- living in the Gedong district sharpened their talents in photography,
blogging, dan musik. Program ini dibuka dengan sebuah workshop pada theater, dance, web-blogging, and music. The program opened with
tanggal 14 April 2013 dan ditutup dengan sebuah program pertunjukan a workshop on April 14, 2013, and the final performances, along with
yang diadakan pada tanggal 30 Juni 2013 di Kantor Merck. the closing event, took place on June 30, 2013 at Merck Office.
3 Mei 2013 3 May 2013
Mengelola Limbah Botol melalui Proyek Retrologistik® Managing Hazardous Bottled Waste through the Retrologistic® Project
Merck Millipore mengadakan seminar tentang “Pengelolaan Limbah Botol Merck Millipore held a seminar on “Managing Hazardous Bottled
melalui Proyek Retrologistik® di Kawasan Industri Jababeka". Para undangan Waste through the Retrologistic® Project in Jababeka Industrial Zone”.
yang merupakan perusahaan-perusahaan yang berlokasi di Kawasan Participating companies, which were all located in the Jababeka Industrial
Industri Jababeka menyaksikan presentasi tentang Proyek Retrologistik® Zone saw a presentation on the implementation of Retrologistic® in
dan penerapannya di Thailand, Indonesia, dan Filipina. Para peserta Thailand, Indonesia and the Philippines. The seminar participants also
seminar juga berkesempatan mengunjungi Fasilitas Pembersihan had a chance to visit the Retrologistic® Cleaning Facility, which manages
(Cleaning Facility) Retrologistik® dan menyaksikan demo proses hazardous glass bottled waste, and watch a demonstration of the
pembersihan dan penghancuran limbah botol bekas pakai. cleaning and crushing of the used glass bottles.
6 Mei 2013 6 May 2013
Peluncuran Kembali Klik Hati Merck serta Pelatihan di 3 Kota Re-Launching of Klik Hati Merck, followed by Training in 3 Cities
CSR Perusahaan diluncurkan kembali dan sekali lagi mengundang The Company’s CSR was re-launched and once again invited
para komunitas aksi sosial khususnya yang menggunakan media members of the social action community, especially that use social
sosial dalam berkomunikasi. Setelah diluncurkan kembali, dari media in their communication. Following the re-launch, from May
bulan Mei hingga Juli, Perseroan mengadakan workshop di Jakarta, to July, the Company held off-air workshops in Jakarta, Bandung
Bandung dan Yogyakarta yang bertujuan untuk berbagi pengetahuan and Yogyakarta. The workshops aimed to share knowledge on how
tentang bagaimana membangun aksi sosial yang berkelanjutan, dan developing sustainable social activity as well as emphasizing it
membesarkannya melalui media sosial. through social media in Indonesia.